PS Ratio: 63.57

Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/S ratio high or low?

The P/S ratio of 63.57 is 28% above its estimated 5-year average of 49.57, around the middle of its estimated 5-year range (2.13–195.79).

As of 2026-10-06T18:55:26.211Z. 14.01% above its estimated 12-month average of 55.76.

ACRS PS Ratio Metrics

P/S vs. estimated history

At 63.57, P/S is near its estimated 9-year median — higher than 64% of readings in its estimated 9-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Sales Valuation

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PS Ratio FAQ

What is the P/S ratio for Aclaris Therapeutics, Inc. (ACRS)?

The P/S ratio for ACRS stock is 63.57.

Is Aclaris Therapeutics, Inc.'s P/S ratio high or low?

The P/S ratio of 63.57 is 28% above its estimated 5-year average of 49.57, around the middle of its estimated 5-year range (2.13–195.79).

What is the estimated TTM average P/S ratio for Aclaris Therapeutics, Inc. (ACRS)?

The estimated TTM average P/S ratio for ACRS stock is 55.76.

What is the estimated 3Y average P/S ratio for Aclaris Therapeutics, Inc. (ACRS)?

The estimated 3Y average P/S ratio for ACRS stock is 9.54.

What is the estimated 5Y average P/S ratio for Aclaris Therapeutics, Inc. (ACRS)?

The estimated 5Y average P/S ratio for ACRS stock is 49.57.

Showing the most recent 260 of 2,237 data points. The chart above shows the full history.

Related Metrics